Arai S. Editorial Comment on Efficacy of Docetaxel Addition to Next-Generation Androgen 
Receptor-Axis-Targeted Therapies and Androgen Deprivation Therapy in Metastatic 
Hormone-Sensitive Prostate Cancer: A Tumor Volume-Specific Analysis. Int J Urol 2025 Aug 21. doi: 10.1111/iju.70208.
PMID: 40838607
|   |  |  | 
